Evommune, Inc. (EVMN)
24.11
+0.48
(+2.03%)
USD |
NYSE |
May 05, 16:00
24.11
0.00 (0.00%)
After-Hours: 20:00
Evommune Market Cap : 868.40M for May 5, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 73.63B |
| Nektar Therapeutics | 1.457B |
| Moderna, Inc. | 18.52B |
| Apogee Therapeutics, Inc. | 5.730B |
| Vertex Pharmaceuticals, Inc. | 107.77B |
Market Cap Related Metrics
| PS Ratio | 57.12 |
| PEG Ratio | -0.2268 |
| Price to Book Value | 4.224 |
| Price | 24.11 |
| Earnings Yield | -9.24% |
| PEGY Ratio | -0.2268 |